Matches in Wikidata for { <http://www.wikidata.org/entity/Q91504911> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91504911 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91504911 description "scientific article published on 28 November 2019" @default.
- Q91504911 description "wetenschappelijk artikel" @default.
- Q91504911 description "наукова стаття, опублікована 28 листопада 2019" @default.
- Q91504911 name "Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma" @default.
- Q91504911 name "Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma" @default.
- Q91504911 type Item @default.
- Q91504911 label "Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma" @default.
- Q91504911 label "Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma" @default.
- Q91504911 prefLabel "Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma" @default.
- Q91504911 prefLabel "Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma" @default.
- Q91504911 P1433 Q91504911-0FA07023-C69A-437F-AEE6-3CC8697FED77 @default.
- Q91504911 P1476 Q91504911-77AA757B-8A15-4D57-ABDA-8E1965B19422 @default.
- Q91504911 P2093 Q91504911-57C22247-7DB0-4B32-A484-E9927D9C70A8 @default.
- Q91504911 P2093 Q91504911-764B8CE4-1E0A-40A7-87E6-7AE231F80DC8 @default.
- Q91504911 P2093 Q91504911-983B168B-D48A-415B-82D5-1B3E7B1572DF @default.
- Q91504911 P2093 Q91504911-F81BE9DB-F7C9-417C-BDB8-CECFF3911361 @default.
- Q91504911 P2860 Q91504911-42A47935-5AC2-4E75-B586-A02E5C3B7497 @default.
- Q91504911 P304 Q91504911-EF407F14-9455-4134-8D6F-7E3B7B60D87F @default.
- Q91504911 P31 Q91504911-71D02D3C-C49D-46A5-9F8D-C29DC501B120 @default.
- Q91504911 P356 Q91504911-925AD352-D996-4397-9DAB-296000C1C95F @default.
- Q91504911 P433 Q91504911-E85C503C-914D-4769-9D94-E7269BFE09A1 @default.
- Q91504911 P478 Q91504911-3C3CD662-2536-48C0-8C14-D1041B0DB82D @default.
- Q91504911 P50 Q91504911-C5DCB681-D42A-4979-A048-530CC63F32FD @default.
- Q91504911 P577 Q91504911-F94AC337-4CFB-42FA-9168-258A1DE3E4B5 @default.
- Q91504911 P698 Q91504911-6100F4C4-922A-4E07-9FA6-DDFCD5466CEB @default.
- Q91504911 P356 CER-2019-0061 @default.
- Q91504911 P698 31778073 @default.
- Q91504911 P1433 Q22080407 @default.
- Q91504911 P1476 "Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma" @default.
- Q91504911 P2093 "Ahmad Tarhini" @default.
- Q91504911 P2093 "Eric Druyts" @default.
- Q91504911 P2093 "Roy Koruth" @default.
- Q91504911 P2093 "Steve Kanters" @default.
- Q91504911 P2860 Q27860760 @default.
- Q91504911 P304 "1349-1363" @default.
- Q91504911 P31 Q13442814 @default.
- Q91504911 P356 "10.2217/CER-2019-0061" @default.
- Q91504911 P433 "16" @default.
- Q91504911 P478 "8" @default.
- Q91504911 P50 Q91110201 @default.
- Q91504911 P577 "2019-11-28T00:00:00Z" @default.
- Q91504911 P698 "31778073" @default.